FDA cites sanitary issues at specialty pharmacies

(AP)—The Food and Drug Administration says it has uncovered troubling sterility problems at 30 specialty pharmacies that were inspected following a recent outbreak of meningitis caused by contaminated drugs.

The agency said its inspectors targeted 31 compounding pharmacies that produce sterile drugs, which must be prepared under highly sanitary conditions.

In an online posting Thursday, the FDA said it issued inspection reports to all but one of the pharmacies listing problems, including: rust and mold in supposedly sterile rooms, inadequate ventilation and employees wearing non-sterile lab coats.

The inspections were conducted between February and April in response to a deadly fungal linked to contaminated steroids. The injections from a Massachusetts pharmacy have caused 53 deaths and 733 illnesses since last summer.


Explore further

Mass. shuts 11 pharmacies following inspections (Update)

Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: FDA cites sanitary issues at specialty pharmacies (2013, April 12) retrieved 26 October 2021 from https://medicalxpress.com/news/2013-04-fda-cites-sanitary-issues-specialty.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors